Akorn Sharpens Focus As It Divests Ophthalmic Brands

Focusing On Human Generics And Animal Care After Completing Sale To Théa Pharma

 
• By Dave Wallace

Akorn says it is concentrating its focus on “targeted avenues of growth” – including human generics and animal care – after divesting its branded ophthalmic portfolio to Théa Pharma.

Glasses Eye Test Chart Vision Focus
Akorn is sharpening the focus of its business with the divestment of its ophthalmic brands • Source: David Izquierdo Roger / Alamy Stock Photo

More from Deals

More from Business